Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for bone loss in subacute spinal cord injury
NCT03029442Phase 4Terminated
- Sponsor
- James J. Peters Veterans Affairs Medical Center
- Start
- Apr 2017
- Primary completion
- Dec 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab in secondary osteoporosis, sponsored by James J. Peters Veterans Affairs Medical Center. Started Apr 2017; status: terminated.
02
Drugs
denosumab
03
Conditions
secondary osteoporosis
Beyond the preview
Go deeper on NCT03029442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03029442.